| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000035484 |
| Receipt No. | R000040424 |
| Scientific Title | The effect of intake of specific food ingredients on human endurance and fatigue |
| Date of disclosure of the study information | 2019/05/01 |
| Last modified on | 2019/07/16 (Ver. 5) |
| Basic information | ||
| Public title | The effect of intake of specific food ingredients on human endurance and fatigue | |
| Acronym | The effect of intake of specific food ingredients on human endurance and fatigue | |
| Scientific Title | The effect of intake of specific food ingredients on human endurance and fatigue | |
| Scientific Title:Acronym | The effect of intake of specific food ingredients on human endurance and fatigue | |
| Region |
|
|
| Condition | |||
| Condition | Healthy male adults | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To elucidate the effects of the intake of tea catechins and amino acids on the blood component during exercise and human endurance |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Endurance on last day of each period (2 days) |
| Key secondary outcomes | Blood component fluctuation, saliva component fluctuation, heart rate variability, rate of perceived exertion (RPE), visual analog scale (VAS) for fatigue at exercise test on last day of each period (2 days) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | No need to know |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of specific food ingredients for 2 days and exercise on the final day.->Washout more than 6 days.->Intake of placebo (without specific food ingredients) for 2 days and exercise on the final day. | |
| Interventions/Control_2 | Intake of placebo (without specific food ingredients) for 2 days and exercise on the final day.->Washout more than 2 weeks.->Intake of specific food ingredients for 2 days and exercise on the final day. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1.A person who is healthy men of 20 to 39 years old
2.A person who can receive physical fitness measurement 3.A person with exercise habits of about once a week 4.A person who is able to comply with the instructions of the person in charge of research 5.A person who is in the Kao Tochigi Plant during the examination period and who can participate in the exam |
|||
| Key exclusion criteria | 1.A person with serious diseases such as liver, kidney, heart, lung, digestive organs, blood, endocrine system and metabolic system
2.Heart failure patients and a person with a history of myocardial infarction 3.A person who has a history of seizures based on nervous system diseases (loss of consciousness, coma, convulsions, etc.) 4.A person with abnormal sugar / lipid metabolism 5.A person who drinks alcohol (alcohol equivalent of 20 g / day or more) 6.Food allergy to wheat, eggs, milk, soybean, apple, pork, and, ingredients derived from gelatin etc 7.A person with severe anemia 8.A person who currently has trouble in the lower limb exercise machine, or who had it within the past 3 months 9.A person with lower physical strength / exercise ability (a person who can not do the bicycle pedaling movement of constant rhythm, a person who can not do persistence exercise for more than 20 minutes) 10.A person who is prohibited from exercising or intense movement from a doctor |
|||
| Target sample size | 16 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Biological Science Research | ||||||
| Zip code | 321-3497 | ||||||
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
| TEL | 0285-68-7817 | ||||||
| minegishi.yoshihiko@kao.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kao Corporation | ||||||
| Division name | Biological Science Research | ||||||
| Zip code | 321-3497 | ||||||
| Address | 2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN | ||||||
| TEL | 0285-68-7817 | ||||||
| Homepage URL | |||||||
| hasumura.takahiro@kao.com | |||||||
| Sponsor | |
| Institute | Kao Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kao Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Human Research Ethics Committee, Kao Corporation |
| Address | 2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN |
| Tel | +81-3-5630-9220 |
| uesaka.toshio@kao.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 花王株式会社(栃木県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 8 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040424 |